We found that in APDS patients 34.9 ± 5.0% (mean ± SEM) of CD8+ T cells express CD57, compared with 25.2 ± 4.0% in healthy controls and 56.4 ± 5.2% in HIV+ patients (Figure 2C). This evidence concerns the gene CD8A and activated PI3K-delta syndrome.